Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joyce Sanders

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Genes, Chromosomes & Cancer|September 11, 2015
Copy number profiling by array comparative genomic hybridization identifies frequently occurring BRCA2-like male breast cancerHedde D Biesma, Philip C Schouten, Miangela M Lacle, et al.
Life Science Alliance|January 9, 2019
Optimized ChIP-seq method facilitates transcription factor profiling in human tumorsAbhishek A Singh, Karianne Schuurman, Ekaterina Nevedomskaya, et al.
BMC Cancer|March 1, 2018
The association of diabetes mellitus and insulin treatment with expression of insulin-related proteins in breast tumorsHeleen K Bronsveld, Marie L De Bruin, Jelle Wesseling, et al.
Cancer Immunology, Immunotherapy : CII|June 25, 2015
Sunitinib pretreatment improves tumor-infiltrating lymphocyte expansion by reduction in intratumoral content of myeloid-derived suppressor cells in human renal cell carcinomaAurelie Guislain, Jules Gadiot, Andrew Kaiser, et al.
Breast (Edinburgh, Scotland)|April 10, 2024
Radiological, pathological and surgical outcomes after neoadjuvant endocrine treatment in patients with ER-positive/HER2-negative breast cancer with a clinical high risk and a low-risk 70-gene signatureJosefien P van Olmen, Chaja F Jacobs, Sanne A L Bartels, et al.
Biomedical Optics Express|July 1, 2022
Discriminating healthy from tumor tissue in breast lumpectomy specimens using deep learning-based hyperspectral imagingLynn-Jade S Jong, Naomi de Kruif, Freija Geldof, et al.
Breast (Edinburgh, Scotland)|August 3, 2022
Efficacy of neoadjuvant treatment with or without pertuzumab in patients with stage II and III HER2-positive breast cancer: a nationwide cohort analysis of pathologic response and 5-year survivalAnna van der Voort, Marte C Liefaard, Mette S van Ramshorst, et al.
Oncoimmunology|October 26, 2020
Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosisSandrine Nugteren, Jeroen A C M Goos, Pien M Delis-van Diemen, et al.
Molecular Oncology|October 19, 2023
Proteomics on malignant pleural effusions reveals ERα loss in metastatic breast cancer associates with SGK1-NDRG1 deregulationIsabel Mayayo-Peralta, Donna O Debets, Stefan Prekovic, et al.
Scientific Reports|March 20, 2025
Toward real-time margin assessment in breast-conserving surgery with hyperspectral imagingLynn-Jade S Jong, Dinusha Veluponnar, Freija Geldof, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Genes, Chromosomes & Cancer|September 11, 2015
Copy number profiling by array comparative genomic hybridization identifies frequently occurring BRCA2-like male breast cancerHedde D Biesma, Philip C Schouten, Miangela M Lacle, et al.
Life Science Alliance|January 9, 2019
Optimized ChIP-seq method facilitates transcription factor profiling in human tumorsAbhishek A Singh, Karianne Schuurman, Ekaterina Nevedomskaya, et al.
BMC Cancer|March 1, 2018
The association of diabetes mellitus and insulin treatment with expression of insulin-related proteins in breast tumorsHeleen K Bronsveld, Marie L De Bruin, Jelle Wesseling, et al.
Cancer Immunology, Immunotherapy : CII|June 25, 2015
Sunitinib pretreatment improves tumor-infiltrating lymphocyte expansion by reduction in intratumoral content of myeloid-derived suppressor cells in human renal cell carcinomaAurelie Guislain, Jules Gadiot, Andrew Kaiser, et al.
Breast (Edinburgh, Scotland)|April 10, 2024
Radiological, pathological and surgical outcomes after neoadjuvant endocrine treatment in patients with ER-positive/HER2-negative breast cancer with a clinical high risk and a low-risk 70-gene signatureJosefien P van Olmen, Chaja F Jacobs, Sanne A L Bartels, et al.
Biomedical Optics Express|July 1, 2022
Discriminating healthy from tumor tissue in breast lumpectomy specimens using deep learning-based hyperspectral imagingLynn-Jade S Jong, Naomi de Kruif, Freija Geldof, et al.
Breast (Edinburgh, Scotland)|August 3, 2022
Efficacy of neoadjuvant treatment with or without pertuzumab in patients with stage II and III HER2-positive breast cancer: a nationwide cohort analysis of pathologic response and 5-year survivalAnna van der Voort, Marte C Liefaard, Mette S van Ramshorst, et al.
Oncoimmunology|October 26, 2020
Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosisSandrine Nugteren, Jeroen A C M Goos, Pien M Delis-van Diemen, et al.
Molecular Oncology|October 19, 2023
Proteomics on malignant pleural effusions reveals ERα loss in metastatic breast cancer associates with SGK1-NDRG1 deregulationIsabel Mayayo-Peralta, Donna O Debets, Stefan Prekovic, et al.
Scientific Reports|March 20, 2025
Toward real-time margin assessment in breast-conserving surgery with hyperspectral imagingLynn-Jade S Jong, Dinusha Veluponnar, Freija Geldof, et al.
Pageof 9